| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1097-0142(19871001)60:7<1651::AID-CNCR2820600738>3.0.CO;2-J |
| P698 | PubMed publication ID | 3621134 |
| P2093 | author name string | Miller DR | |
| Lansky LL | |||
| Lansky SB | |||
| List MA | |||
| Ritter-Sterr C | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | childhood cancer | Q5097977 |
| patient | Q181600 | ||
| P304 | page(s) | 1651-1656 | |
| P577 | publication date | 1987-10-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | The measurement of performance in childhood cancer patients | |
| P478 | volume | 60 |
| Q38070330 | A comprehensive analysis of early outcomes and complication rates after 769 craniotomies in pediatric patients |
| Q38569761 | A glimpse into the lives of 3 children: their cancer journey |
| Q28345464 | A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation |
| Q33400103 | A positioning pillow to improve lumbar puncture success rate in paediatric haematology-oncology patients: a randomized controlled trial |
| Q34156087 | A review of measures of quality of life for children with chronic illness |
| Q75382137 | Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience |
| Q79181641 | Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia |
| Q36522032 | An fMRI investigation of working memory and its relationship with cardiorespiratory fitness in pediatric posterior fossa tumor survivors who received cranial radiation therapy |
| Q73245572 | Antecedents, concomitants, and consequences of pediatric headache: confirmatory construct validation of two parent-report scales |
| Q24186174 | Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood |
| Q33624416 | Assessment of health status in survivors of cancer |
| Q52234708 | Assessment of the Terminally Ill Patient with Pain: The Example of Cancer |
| Q55484901 | Astrocytoma in Childhood: Survival and Performance |
| Q84115684 | Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL |
| Q36176224 | Cardiorespiratory fitness in survivors of pediatric posterior fossa tumor |
| Q99585415 | Cerebellar lesions at a young age predict poorer long-term functional recovery |
| Q36102052 | Changes in Antioxidant Defense System Using Different Lipid Emulsions in Parenteral Nutrition in Children after Hematopoietic Stem Cell Transplantation |
| Q92358462 | Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer |
| Q36914415 | Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors |
| Q47369732 | Comprehensive assessment of the health status of extremely low birth weight children at eight years of age: comparison with a reference group |
| Q73398612 | Construct validity of newly developed quality of life assessment instrument for child and adolescent cancer patients in Taiwan |
| Q34094097 | Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies |
| Q36807237 | Depression in Pediatric Illness |
| Q36546059 | Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma |
| Q50054903 | Development of a novel observer reported outcome tool as the primary efficacy outcome measure for a rare disease randomized controlled trial. |
| Q34417556 | Developmental therapeutics in childhood cancer. A perspective from the Children's Oncology Group and the US Food and Drug Administration |
| Q36706889 | Early treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery |
| Q35256521 | Enteral nutrition after bone marrow transplantation |
| Q48888712 | Evaluating the ability to detect change of health-related quality of life in children with Hodgkin disease |
| Q92431938 | Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment |
| Q80538904 | Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhood |
| Q30382332 | Following Young Children's Health and Functioning in Everyday Life Through Their Cancer Trajectory. |
| Q90153033 | Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates |
| Q34799647 | Gastrointestinal and nutritional sequelae of bone marrow transplantation |
| Q36513759 | Good clinical practice and the conduct of clinical studies in pediatric oncology |
| Q47204887 | Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. |
| Q33740422 | Health status of children with special health care needs: measurement issues and instruments |
| Q37171833 | Health-related quality of life in survivors of BMT for paediatric malignancy: a systematic review of the literature |
| Q48135813 | Health-related quality of life in survivors of tumours of the central nervous system in childhood--a preference-based approach to measurement in a cross-sectional study |
| Q44835989 | High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors |
| Q45272426 | High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. |
| Q47662810 | Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1). |
| Q37737382 | Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial. |
| Q38783476 | Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour. |
| Q46529379 | Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning |
| Q50334129 | Improvement of life quality measured by Lansky Score after enzymatic replacement therapy in children with Gaucher disease type 1. |
| Q51716743 | Inflammatory Response Using Different Lipid Parenteral Nutrition Formulas in Children After Hematopoietic Stem Cell Transplantation. |
| Q52893057 | Influence of proxy respondents and mode of administration on health status assessment following central nervous system tumours in childhood. |
| Q43613028 | Intensive enteral nutrition support in paediatric bone marrow transplantation |
| Q87157417 | Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia |
| Q73955543 | Long-term results of CD34(+) cell transplantation in children with neuroblastoma |
| Q46202497 | Massage therapy for children with cancer |
| Q36118160 | Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial |
| Q33924937 | Modern Outcomes of Mechanical Circulatory Support as a Bridge to Pediatric Heart Transplantation |
| Q48129524 | Monitoring and Alleviation of Symptom Occurrence and Severity Among Thai Children and Adolescents During Cancer Treatments |
| Q81042768 | Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT) |
| Q34452064 | Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi |
| Q49645053 | Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study |
| Q37067386 | Non Activated Protein C Supplementation in Septic Pediatric Hematological Patients |
| Q47930005 | Nutritional Status in Childhood Malignancies |
| Q24187764 | Nutritional support in children and young people with cancer undergoing chemotherapy |
| Q24234149 | Nutritional support in children and young people with cancer undergoing chemotherapy |
| Q77330900 | Nutritional support in children undergoing bone marrow transplantation |
| Q44177466 | On the origin of EEG-slowing and encephalopathy during induction treatment of acute lymphoblastic leukemia |
| Q64256478 | Oncology Association of Naturopathic Physicians: Principles of Care Guidelines |
| Q36868702 | Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies |
| Q46667195 | Pediatric Low-Grade Gliomas: Next Biologically Driven Steps |
| Q43872880 | Pediatric bone marrow transplants: psychological aspects |
| Q33414370 | Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus |
| Q34520470 | Phase I clinical trial of valacyclovir and standard of care cyclophosphamide in children with endemic Burkitt lymphoma in Malawi |
| Q57571627 | Phase I study of interleukin-6 in children with solid tumours in relapse |
| Q28359347 | Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study |
| Q41175752 | Phase I trials in paediatric oncology--the European perspective. The New Agents Group of the United Kingdom Childrens Cancer Study Group |
| Q37409741 | Physical functioning in pediatric survivors of childhood posterior fossa brain tumors |
| Q39712588 | Pilot Study of Parent Psychophysiologic Outcomes in Pediatric Hematopoietic Stem Cell Transplantation |
| Q45001795 | Predictors of physical outcomes in pediatric bone marrow transplantation |
| Q40500204 | Prevalence and outcomes of heart transplantation in children with intellectual disability. |
| Q92206209 | Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents |
| Q37665337 | Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis |
| Q41473657 | Psychological preparation for nasogastric feeding in children |
| Q53571892 | Psychometric properties of the Health Utilities Index Mark 2 system in paediatric oncology patients. |
| Q81816373 | Quality of life and health in children following allogeneic SCT |
| Q40903176 | Quality of life in cancer: definition, purpose, and method of measurement |
| Q53625164 | Quality of life in early adolescence: a sixteen-dimensional health-related measure (16D). |
| Q53387415 | Quality of life of children and adolescents after kidney or liver transplantation: child, parents and caregiver's point of view. |
| Q48640784 | Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients |
| Q48087136 | Relationship between problems related to child late effects and parent burnout after pediatric hematopoietic stem cell transplantation. |
| Q40880981 | Report on the international workshop of the Kind Philipp Foundation on late effects after bone marrow transplantation in childhood malignancies |
| Q36431043 | School behaviour and health status after central nervous system tumours in childhood |
| Q45087247 | Sickness behavior clustering in children with cancer |
| Q67793030 | Stress Responses after Pediatric Bone Marrow Transplantation: Preliminary Results of a Prospective Longitudinal Study |
| Q53125598 | Successful treatment of a recurrent choroid plexus carcinoma with surgery followed by high-dose chemotherapy and stem cell rescue. |
| Q94322619 | Temozolomide for children and adolescents with diffuse intrinsic pontine glioma |
| Q24200164 | Temozolomide for children and adolescents with diffuse intrinsic pontine glioma |
| Q95289284 | The Importance of Engaging Children in Research Decision-Making: A Preliminary Mixed-Methods Study |
| Q35976910 | The comprehensive assessment of health status in survivors of childhood cancer: application to high-risk acute lymphoblastic leukaemia |
| Q41827888 | The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit |
| Q30331707 | The effects of interactive music therapy on hospitalized children with cancer: a pilot study. |
| Q38026472 | The fifth vital sign: chronic pain assessment of the adolescent oncology patient |
| Q47576193 | The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma. |
| Q40759632 | The measurement of symptoms in children with cancer. |
| Q92446598 | The timing, duration, and management of symptoms of children with an incurable brain tumor: a retrospective study of the palliative phase |
| Q50353862 | Topotecan for pediatric patients with resistant and recurrent solid tumors |
| Q55432258 | Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy. |
| Q39176042 | Transdermal Fentanyl for Cancer Pain Management in Opioid-Naive Pediatric Cancer Patients |
| Q39413901 | Transdermal fentanyl for pain relief in a paediatric palliative care population |
| Q39359241 | Transdermal fentanyl in the management of children with chronic severe pain: results from an international study |
| Q44973647 | Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease |
| Q36501354 | Trends in haematopoietic cell transplantation for inborn errors of metabolism |
| Q41922014 | Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children. |
| Q38604209 | Understanding Treatment Burden and Quality of Life Impact of Participating in an Early-Phase Pediatric Oncology Clinical Trial: A Pilot Study |
| Q45854748 | Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse |
| Q47370043 | Validation of the Airway-Dyspnoea-Voice-Swallow (ADVS) scale and Patient-Reported Outcome Measure (PROM) as disease-specific instruments in paediatric laryngotracheal stenosis |
| Q104491924 | Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure |
| Q40259951 | Validity, specificity, feasibility and acceptability of a brief pediatric distress thermometer in outpatient clinics |
| Q55472263 | [Brainstem gliomas] |
| Q80269423 | [High-dose chemotherapy with autologous stem cell rescue in children with high-risk and recurrent brain tumors] |
Search more.